Page last updated: 2024-09-05

zm 241385 and 1-ethyl-2-benzimidazolinone

zm 241385 has been researched along with 1-ethyl-2-benzimidazolinone in 1 studies

Compound Research Comparison

Studies
(zm 241385)
Trials
(zm 241385)
Recent Studies (post-2010)
(zm 241385)
Studies
(1-ethyl-2-benzimidazolinone)
Trials
(1-ethyl-2-benzimidazolinone)
Recent Studies (post-2010) (1-ethyl-2-benzimidazolinone)
4013124126037

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bradding, P; Brightling, CE; Cruse, G; Duffy, SM1

Other Studies

1 other study(ies) available for zm 241385 and 1-ethyl-2-benzimidazolinone

ArticleYear
Adenosine closes the K+ channel KCa3.1 in human lung mast cells and inhibits their migration via the adenosine A2A receptor.
    European journal of immunology, 2007, Volume: 37, Issue:6

    Topics: Adenosine; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Benzimidazoles; Calcium Channel Agonists; Cations; Cell Movement; Culture Media, Conditioned; Electric Stimulation; Electrophysiology; Histamine; Humans; Immunoglobulin E; Intermediate-Conductance Calcium-Activated Potassium Channels; Lung; Mast Cells; Phenethylamines; Receptor, Adenosine A2A; Receptor, Adenosine A2B; Triazines; Triazoles

2007